Targeting thrombogenicity and inflammation in chronic HIV infection. [electronic resource]
Producer: 20200501Description: eaav5463 p. digitalISSN:- 2375-2548
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Antiretroviral Therapy, Highly Active -- methods
- Aspirin -- therapeutic use
- Biomarkers -- blood
- Blood Platelets -- drug effects
- Clopidogrel -- therapeutic use
- Coronary Thrombosis -- complications
- Cross-Sectional Studies
- Female
- Fibrin Fibrinogen Degradation Products -- genetics
- Gene Expression
- HIV Infections -- complications
- Humans
- Immunity, Innate
- Inflammation
- Lipopolysaccharide Receptors -- genetics
- Male
- Middle Aged
- Monocytes -- drug effects
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- therapeutic use
- Receptors, Tumor Necrosis Factor, Type I -- genetics
- Receptors, Tumor Necrosis Factor, Type II -- genetics
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.